DRTS
Alpha Tau Medical Ltd. Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$13.06Close
$1.1BMarket cap
$3.47 – $15.5052-week range
Nov 19, 2026Next report
Highlights
Strengths
- Leading the market RS 97 · stronger than 97% of stocks over 12 months
Cautions
- Trend not confirmed 7 of 8 conditions · under the 50-day
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
16%
1wk
down 0.8%
price change
1mo
down 12.4%
price change
12-month return
up 223%
market up 11% ·
its own up 208%
F-score
—
— Not assessed
Altman Z
—
Unknown
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
14.9×
price / book
Earnings yield
down 3.7%
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
—
year on year
EPS growth
—
latest quarter
Sales growth
—
latest quarter
ROE
down 61%
return on equity
Free cash margin
—
-$32.8M FCF
D/E
0.08
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Trade setup
ATR%
4.8%
$0.63 a day · 2×ATR $11.80
RS
97 / 99
vs the universe
Trend
7 / 8
under the 50-day
Relative volume
0.9×
vs 50-day average
Up/down volume
0.68
50 sessions
Implied move
—
no option chain · report Nov 19, 2026
Trend template · 7 of 8
- Price above the 50-day average: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Shareholders diluted The share count rose 25.0% over the year, from 70m to 88m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Financials
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Operating income | -$9.2M | -$13.8M | -$32.1M | -$35.7M | -$36.0M | -$42.3M |
| Net income | -$8.9M | -$27.3M | -$33.8M | -$29.2M | -$31.8M | -$42.6M |
| Earnings per share | -$0.22 | -$0.67 | -$0.53 | -$0.42 | -$0.45 | -$0.53 |
| Free cash flow | -$11.0M | -$14.7M | -$24.8M | -$24.4M | -$22.0M | -$32.8M |
| Cash | $15.6M | $23.2M | $5.8M | $12.7M | $13.7M | $12.2M |
| Long-term debt | — | — | — | $5.6M | $5.6M | $6.4M |
| Shareholders' equity | -$8.4M | -$34.8M | $105.7M | $84.5M | $62.7M | $77.1M |
| Shares outstanding | 40.43m | 40.53m | 69.11m | 69.67m | 70.38m | 88.01m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Mar 9, 2026 | Annual ↗ | Dec 31, 2025 | 68d |
| Aug 11, 2025 | Interim ↗ | Jun 30, 2025 | 42d |
| Mar 12, 2025 | Annual ↗ | Dec 31, 2024 | 71d |
| Aug 14, 2024 | Interim ↗ | Jun 30, 2024 | 45d |
| Mar 7, 2024 | Annual ↗ | Dec 31, 2023 | 67d |
| Aug 28, 2023 | Interim ↗ | Jun 30, 2023 | 59d |
| Mar 9, 2023 | Annual ↗ | Dec 31, 2022 | 68d |
| Mar 28, 2022 | Annual ↗ | Dec 31, 2021 | 87d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 29, 2026 | Foreign issuer report ↗ |
| Oct 22, 2026 | Foreign issuer report ↗ |
| Oct 19, 2026 | Foreign issuer report ↗ |
| Aug 31, 2026 | Foreign issuer report ↗ |
| Aug 10, 2026 | Foreign issuer report ↗ |
| Aug 10, 2026 | Foreign issuer report ↗ |
| Jul 21, 2026 | Foreign issuer report ↗ |
| Jul 15, 2026 | Foreign issuer report ↗ |
| Jun 25, 2026 | Foreign issuer report ↗ |
| Jun 23, 2026 | Foreign issuer report ↗ |
| Jun 11, 2026 | Foreign issuer report ↗ |
| Jun 3, 2026 | Foreign issuer report ↗ |